TrialJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2022

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.

Robert J Pignolo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.